Myeloma Foundation Claims Controversial Drug Report Could Limit Access to Best Treatments
The International Myeloma Foundation (IMF), the largest organization…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Data on Combo Therapy for Multiple Myeloma to Be Presented by PharmaMar at ASCO Meeting
Positive data for the Phase 1 trial of…
Amgen to Present New Data on Kyprolis, a Multiple Myeloma Treatment, at EHA 2016
Amgen announced it will present new data on its cancer…
New Data on Myeloma Drug Candidates to Be Presented by PharmaMar at Oncology Meeting
Spain-based PharmaMar announced the company will present data from…
Phase 3 Study of Stem Cell Transplantation in Multiple Myeloma Patients Showing Early Benefits
Results from an ongoing clinical trial supports the use…
Ongoing Phase 3 Study Finds Daratumumab Improves Survival in Advanced Multiple Myeloma Patients
Genmab has announced positive results from its Phase 3…
